Le Lézard
Classified in: Science and technology, Business
Subjects: AWD, SVY

T3 Fusion Website Rankings Names Regional Finalists for 2024


Sixteen finalists recognized for excellence in website design, functionality and performance among residential real estate brokerages

SCOTTSDALE, Ariz., April 24, 2024 /PRNewswire-PRWeb/ -- T3 Sixty, a strategic management consulting firm in the residential real estate industry, today announced sixteen finalists in the first T3 Fusion Website Rankings during the 11th annual T3 Leadership Summit. This award honors excellence in website design, functionality and performance among residential real estate brokerages.

"These rankings celebrate some of the best brokerage websites in the real estate industry. We are thrilled to shine a light on these best-in-class websites," said Michael Phelan, senior vice president of technology consulting at T3 Sixty.

"These rankings celebrate some of the best brokerage websites in the real estate industry. The collaboration between the brokerage and its tech vendors has led to sites that blend the ability to perform well in the eyes of Google, engage visitors and reinforce the firm's brand. We are thrilled to shine a light on these best-in-class websites," said Michael Phelan, senior vice president of technology consulting at T3 Sixty.

T3 Sixty collaborated with Benchmetrics, ListTrac, LiveBy and MAXA Designs to conduct a comprehensive evaluation of more than 500 submissions. Desktop and mobile versions of the websites were evaluated across 28 factors for their performance, usability and design with special consideration given to property and neighborhood detail pages.

The T3 Fusion Website Rankings finalists represent brokerages spanning five zones across North America.

Canada

Midwest

Northeast

Southeast

West Coast

About T3 Sixty
T3 Sixty is a management consultancy in the residential real estate industry with business units in brokerage, technology, mergers and acquisitions, and organized real estate. The group also provides software and data, extensive research and reports, executive search and event management services. For more information, visit t360.com.

Media Contact

Cynthia Nowak, T3 Sixty, LLC., 949.397.2108, [email protected], t360.com

SOURCE T3 Sixty, LLC.


These press releases may also interest you

at 17:35
Perficient to be Acquired by EQT for Approximately $3.0 Billion
Perficient, Inc. ("Perficient" or "the Company"), a leading global digital consultancy transforming the world's largest enterprises and biggest brands, today announced that it has entered into a definitive agreement to be acquired by an affiliate of...

at 17:35
Perficient Reports First Quarter 2024 Results
Perficient, Inc. ("Perficient"), the leading global digital consultancy transforming the world's largest enterprises and biggest brands, today reported its financial results for the quarter ended March 31, 2024. Financial Highlights For the...

at 15:32
Spectacular revival of Marco Polo captivated global audience
A report from GDToday:  On the evening of May 3, 2024, the Guangzhou Opera House dazzled audiences with the performance of "Marco Polo," a captivating opera commissioned by the esteemed venue. In order to commemorate the 700th anniversary of the...

at 13:20
Community Capital's Garrett Smith Attends Milken Institute Global Conference
Garrett Smith, Founder and CEO of Community Capital Technology Inc. ("Community Capital"), will be attending the Milken Institute Global Conference ("MI Global") May 5-8, 2024 in Los Angeles. The event brings together global executives and...

at 13:16
Quarterhill Announces Sponsorship and Participation at IBTTA Technology Summit
Quarterhill Inc. ("Quarterhill" or the "Company") , a leading provider of tolling and enforcement solutions in the Intelligent Transportation System ("ITS")...

at 12:25
New Real-World Retrospective Analysis Presented at AUA 2024 Reports 86% Recurrence-Free Survival (RFS) at 24 Months with JELMYTO® Across All Studied Patient and Disease Characteristics in Cohort of Responders to Induction Therapy
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from the first and largest real-world patient cohort review...

More news about Science and technology...


News published on and distributed by: